The Abu Dhabi Investment Office (ADIO) announced plans to expand its San Francisco operations to strengthen investment ties with the US health sector. The expansion aims to support the emirate’s Health, Endurance, Longevity, and Medicine (HELM) cluster, which seeks to contribute $25.6 billion to Abu Dhabi’s GDP and create 30,000 jobs by 2045.
ADIO’s San Francisco office will serve as a platform for US-based health tech startups and scale-ups to access Abu Dhabi’s regulatory pathways and investment opportunities. The HELM cluster focuses on areas such as genomics, AI in healthcare, and population health intelligence.
The announcement coincided with a delegation visit to San Francisco, led by HE Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi, to engage with health technology and innovation sector stakeholders.
Abu Dhabi’s strategy includes attracting global health innovators to its ecosystem and offering fast-track clinical validation and regulatory support. The emirate aims to position itself as a hub for health innovation, leveraging partnerships with institutions like Insilico Medicine and Innovaccer.
The expansion of ADIO’s San Francisco office is part of a broader initiative to promote Abu Dhabi’s economic clusters and attract foreign investment in key sectors.
